{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Practical Interpretation of 18F PSMA PET/CT: Spectrum of Findings - Vol. 46, No. 21
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Description
Method of Participation in the Learning Process/Evaluation Method Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form. Getting the Most out of the Activity As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed. While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.Learning Objectives
After completing this continuing education activity you will be able to:
Interpret 18F DCFPyL PET/CT imaging for the diagnosis, staging, therapeutic monitoring, and management of patients with prostate cancer, and explain its advantages and potential pitfalls.
Disclosures
All authors, faculty, and staff have no relevant financial relationships with any ineligible organizations regarding this educational activity.
Price:
$49.00
Credits:
- ACCME 2.0 CME
Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Professions:
Physician
Test Code: CDR1023
Published: October 15, 2023
Expires: 10/14/2025
Sources:
Contemporary Diagnostic Radiology
Required Passing Score: 6/8 (75%)
Categories:
Imaging
Specialties:
Radiology
Topics:
18F PSMA PET/CT
,
Prostate Cancer